Ambu A/S
Get $10 bonus on your first $100 deposit for AMBBY
Get $10 bonus on your first $100 deposit for AMBBY
Ambu A/S (AMBBY) Stock Competitors & Peer Comparison
See (AMBBY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMBBY | $11.00 | +4.36% | 2.9B | 34.38 | $0.32 | +0.58% |
| SEMHF | $44.43 | -3.07% | 49.6B | 20.10 | $2.21 | +2.68% |
| RYLPF | $28.70 | +0.00% | 27.3B | 26.57 | $1.08 | +3.31% |
| SMMNY | $22.84 | +1.60% | 25.5B | 20.39 | $1.12 | +2.60% |
| SONVY | $48.85 | +2.35% | 14.5B | 22.18 | $2.20 | +2.20% |
| SONVF | $229.04 | +0.00% | 13.7B | 20.82 | $11.00 | +2.37% |
| SNNUF | $15.55 | -0.96% | 13.3B | 21.60 | $0.72 | +2.53% |
| CHEOF | $125.00 | +0.00% | 8.2B | 30.41 | $4.11 | +2.35% |
| CHEOY | $61.21 | +0.99% | 8B | 32.73 | $1.87 | +2.37% |
| WILYY | $16.60 | +0.00% | 7B | 19.08 | $0.87 | N/A |
Stock Comparison
AMBBY vs SEMHF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, SEMHF has a market cap of 49.6B. Regarding current trading prices, AMBBY is priced at $11.00, while SEMHF trades at $44.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas SEMHF's P/E ratio is 20.10. In terms of profitability, AMBBY's ROE is +0.09%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, AMBBY is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SEMHF's competition here
AMBBY vs RYLPF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, RYLPF has a market cap of 27.3B. Regarding current trading prices, AMBBY is priced at $11.00, while RYLPF trades at $28.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas RYLPF's P/E ratio is 26.57. In terms of profitability, AMBBY's ROE is +0.09%, compared to RYLPF's ROE of +0.08%. Regarding short-term risk, AMBBY is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RYLPF's competition here
AMBBY vs SMMNY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, SMMNY has a market cap of 25.5B. Regarding current trading prices, AMBBY is priced at $11.00, while SMMNY trades at $22.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas SMMNY's P/E ratio is 20.39. In terms of profitability, AMBBY's ROE is +0.09%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, AMBBY is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SMMNY's competition here
AMBBY vs SONVY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, SONVY has a market cap of 14.5B. Regarding current trading prices, AMBBY is priced at $11.00, while SONVY trades at $48.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas SONVY's P/E ratio is 22.18. In terms of profitability, AMBBY's ROE is +0.09%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, AMBBY is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SONVY's competition here
AMBBY vs SONVF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, SONVF has a market cap of 13.7B. Regarding current trading prices, AMBBY is priced at $11.00, while SONVF trades at $229.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas SONVF's P/E ratio is 20.82. In terms of profitability, AMBBY's ROE is +0.09%, compared to SONVF's ROE of +0.20%. Regarding short-term risk, AMBBY is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SONVF's competition here
AMBBY vs SNNUF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, SNNUF has a market cap of 13.3B. Regarding current trading prices, AMBBY is priced at $11.00, while SNNUF trades at $15.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas SNNUF's P/E ratio is 21.60. In terms of profitability, AMBBY's ROE is +0.09%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, AMBBY is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SNNUF's competition here
AMBBY vs CHEOF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CHEOF has a market cap of 8.2B. Regarding current trading prices, AMBBY is priced at $11.00, while CHEOF trades at $125.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CHEOF's P/E ratio is 30.41. In terms of profitability, AMBBY's ROE is +0.09%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, AMBBY and CHEOF have similar daily volatility (0.00).Check CHEOF's competition here
AMBBY vs CHEOY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CHEOY has a market cap of 8B. Regarding current trading prices, AMBBY is priced at $11.00, while CHEOY trades at $61.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CHEOY's P/E ratio is 32.73. In terms of profitability, AMBBY's ROE is +0.09%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, AMBBY is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check CHEOY's competition here
AMBBY vs WILYY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, WILYY has a market cap of 7B. Regarding current trading prices, AMBBY is priced at $11.00, while WILYY trades at $16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas WILYY's P/E ratio is 19.08. In terms of profitability, AMBBY's ROE is +0.09%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, AMBBY is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check WILYY's competition here
AMBBY vs WILLF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, WILLF has a market cap of 6.3B. Regarding current trading prices, AMBBY is priced at $11.00, while WILLF trades at $29.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas WILLF's P/E ratio is 16.94. In terms of profitability, AMBBY's ROE is +0.09%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, AMBBY is less volatile compared to WILLF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check WILLF's competition here
AMBBY vs GNGBY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, GNGBY has a market cap of 6B. Regarding current trading prices, AMBBY is priced at $11.00, while GNGBY trades at $21.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas GNGBY's P/E ratio is 24.52. In terms of profitability, AMBBY's ROE is +0.09%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, AMBBY is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check GNGBY's competition here
AMBBY vs GNGBF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, GNGBF has a market cap of 5.9B. Regarding current trading prices, AMBBY is priced at $11.00, while GNGBF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas GNGBF's P/E ratio is 25.25. In terms of profitability, AMBBY's ROE is +0.09%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, AMBBY and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here
AMBBY vs AMBFF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, AMBFF has a market cap of 3.7B. Regarding current trading prices, AMBBY is priced at $11.00, while AMBFF trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas AMBFF's P/E ratio is 42.66. In terms of profitability, AMBBY's ROE is +0.09%, compared to AMBFF's ROE of +0.09%. Regarding short-term risk, AMBBY is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check AMBFF's competition here
AMBBY vs NHNKY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, NHNKY has a market cap of 3.2B. Regarding current trading prices, AMBBY is priced at $11.00, while NHNKY trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas NHNKY's P/E ratio is 14.40. In terms of profitability, AMBBY's ROE is +0.09%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, AMBBY is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check NHNKY's competition here
AMBBY vs MCRPF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, MCRPF has a market cap of 3B. Regarding current trading prices, AMBBY is priced at $11.00, while MCRPF trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas MCRPF's P/E ratio is -17.44. In terms of profitability, AMBBY's ROE is +0.09%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, AMBBY and MCRPF have similar daily volatility (0.00).Check MCRPF's competition here
AMBBY vs FDMDF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, FDMDF has a market cap of 2.8B. Regarding current trading prices, AMBBY is priced at $11.00, while FDMDF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas FDMDF's P/E ratio is -16.21. In terms of profitability, AMBBY's ROE is +0.09%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, AMBBY is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check FDMDF's competition here
AMBBY vs GNNDY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, GNNDY has a market cap of 2.5B. Regarding current trading prices, AMBBY is priced at $11.00, while GNNDY trades at $51.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas GNNDY's P/E ratio is 24.74. In terms of profitability, AMBBY's ROE is +0.09%, compared to GNNDY's ROE of +0.06%. Regarding short-term risk, AMBBY is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check GNNDY's competition here
AMBBY vs NHNKF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, NHNKF has a market cap of 2.4B. Regarding current trading prices, AMBBY is priced at $11.00, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, AMBBY's ROE is +0.09%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, AMBBY is less volatile compared to NHNKF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check NHNKF's competition here
AMBBY vs DRWKF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, DRWKF has a market cap of 2.2B. Regarding current trading prices, AMBBY is priced at $11.00, while DRWKF trades at $116.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas DRWKF's P/E ratio is 13.38. In terms of profitability, AMBBY's ROE is +0.09%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, AMBBY is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check DRWKF's competition here
AMBBY vs GGNDF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, AMBBY is priced at $11.00, while GGNDF trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas GGNDF's P/E ratio is 20.19. In terms of profitability, AMBBY's ROE is +0.09%, compared to GGNDF's ROE of +0.06%. Regarding short-term risk, AMBBY is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check GGNDF's competition here
AMBBY vs OSSFF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, AMBBY is priced at $11.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas OSSFF's P/E ratio is 20.75. In terms of profitability, AMBBY's ROE is +0.09%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, AMBBY is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check OSSFF's competition here
AMBBY vs DWRKF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, AMBBY is priced at $11.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, AMBBY's ROE is +0.09%, compared to DWRKF's ROE of N/A. Regarding short-term risk, AMBBY and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here
AMBBY vs STSEY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, STSEY has a market cap of 1.7B. Regarding current trading prices, AMBBY is priced at $11.00, while STSEY trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas STSEY's P/E ratio is 18.37. In terms of profitability, AMBBY's ROE is +0.09%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, AMBBY and STSEY have similar daily volatility (0.00).Check STSEY's competition here
AMBBY vs MEDGF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, AMBBY is priced at $11.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, AMBBY's ROE is +0.09%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, AMBBY and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here
AMBBY vs OSSUY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, OSSUY has a market cap of 1.6B. Regarding current trading prices, AMBBY is priced at $11.00, while OSSUY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas OSSUY's P/E ratio is 19.08. In terms of profitability, AMBBY's ROE is +0.09%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, AMBBY is less volatile compared to OSSUY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check OSSUY's competition here
AMBBY vs VTRLY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, AMBBY is priced at $11.00, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas VTRLY's P/E ratio is -2.76. In terms of profitability, AMBBY's ROE is +0.09%, compared to VTRLY's ROE of -0.42%. Regarding short-term risk, AMBBY and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here
AMBBY vs DGWPF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, DGWPF has a market cap of 1.5B. Regarding current trading prices, AMBBY is priced at $11.00, while DGWPF trades at $76.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas DGWPF's P/E ratio is 8.81. In terms of profitability, AMBBY's ROE is +0.09%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, AMBBY is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check DGWPF's competition here
AMBBY vs MDRSF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, AMBBY is priced at $11.00, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, AMBBY's ROE is +0.09%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, AMBBY and MDRSF have similar daily volatility (0.00).Check MDRSF's competition here
AMBBY vs ELEAF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, ELEAF has a market cap of 1.3B. Regarding current trading prices, AMBBY is priced at $11.00, while ELEAF trades at $15.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas ELEAF's P/E ratio is 21.83. In terms of profitability, AMBBY's ROE is +0.09%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, AMBBY is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ELEAF's competition here
AMBBY vs LFTSF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, AMBBY is priced at $11.00, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, AMBBY's ROE is +0.09%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, AMBBY and LFTSF have similar daily volatility (0.00).Check LFTSF's competition here
AMBBY vs XVIPF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, XVIPF has a market cap of 718.5M. Regarding current trading prices, AMBBY is priced at $11.00, while XVIPF trades at $22.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas XVIPF's P/E ratio is 253.45. In terms of profitability, AMBBY's ROE is +0.09%, compared to XVIPF's ROE of +0.01%. Regarding short-term risk, AMBBY is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check XVIPF's competition here
AMBBY vs BRSYF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, BRSYF has a market cap of 542.4M. Regarding current trading prices, AMBBY is priced at $11.00, while BRSYF trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas BRSYF's P/E ratio is 75.28. In terms of profitability, AMBBY's ROE is +0.09%, compared to BRSYF's ROE of +0.12%. Regarding short-term risk, AMBBY is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check BRSYF's competition here
AMBBY vs CALZF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CALZF has a market cap of 501.6M. Regarding current trading prices, AMBBY is priced at $11.00, while CALZF trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CALZF's P/E ratio is 72.60. In terms of profitability, AMBBY's ROE is +0.09%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, AMBBY and CALZF have similar daily volatility (0.00).Check CALZF's competition here
AMBBY vs AVMR Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, AMBBY is priced at $11.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas AVMR's P/E ratio is -18.34. In terms of profitability, AMBBY's ROE is +0.09%, compared to AVMR's ROE of -0.30%. Regarding short-term risk, AMBBY and AVMR have similar daily volatility (0.00).Check AVMR's competition here
AMBBY vs IOBCF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, IOBCF has a market cap of 485M. Regarding current trading prices, AMBBY is priced at $11.00, while IOBCF trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas IOBCF's P/E ratio is 32.45. In terms of profitability, AMBBY's ROE is +0.09%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, AMBBY is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check IOBCF's competition here
AMBBY vs DMTRF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, AMBBY is priced at $11.00, while DMTRF trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, AMBBY is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check DMTRF's competition here
AMBBY vs CLVSF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CLVSF has a market cap of 384.8M. Regarding current trading prices, AMBBY is priced at $11.00, while CLVSF trades at $16.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CLVSF's P/E ratio is 23.38. In terms of profitability, AMBBY's ROE is +0.09%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, AMBBY is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check CLVSF's competition here
AMBBY vs CSSPF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CSSPF has a market cap of 384.6M. Regarding current trading prices, AMBBY is priced at $11.00, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, AMBBY is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check CSSPF's competition here
AMBBY vs HYBT Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, AMBBY is priced at $11.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas HYBT's P/E ratio is N/A. In terms of profitability, AMBBY's ROE is +0.09%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, AMBBY and HYBT have similar daily volatility (0.00).Check HYBT's competition here
AMBBY vs CYBQY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CYBQY has a market cap of 316.7M. Regarding current trading prices, AMBBY is priced at $11.00, while CYBQY trades at $1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CYBQY's P/E ratio is -177.60. In terms of profitability, AMBBY's ROE is +0.09%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, AMBBY and CYBQY have similar daily volatility (0.00).Check CYBQY's competition here
AMBBY vs HTLZF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, AMBBY is priced at $11.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, AMBBY's ROE is +0.09%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, AMBBY and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here
AMBBY vs IMPZY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, IMPZY has a market cap of 209.3M. Regarding current trading prices, AMBBY is priced at $11.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, AMBBY's ROE is +0.09%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, AMBBY and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here
AMBBY vs CYBQF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CYBQF has a market cap of 206.8M. Regarding current trading prices, AMBBY is priced at $11.00, while CYBQF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CYBQF's P/E ratio is -155.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, AMBBY and CYBQF have similar daily volatility (0.00).Check CYBQF's competition here
AMBBY vs VMTHF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, AMBBY is priced at $11.00, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, AMBBY's ROE is +0.09%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, AMBBY and VMTHF have similar daily volatility (0.00).Check VMTHF's competition here
AMBBY vs DTXMF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, AMBBY is priced at $11.00, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, AMBBY's ROE is +0.09%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, AMBBY is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check DTXMF's competition here
AMBBY vs BCCOY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, BCCOY has a market cap of 161.9M. Regarding current trading prices, AMBBY is priced at $11.00, while BCCOY trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas BCCOY's P/E ratio is -0.96. In terms of profitability, AMBBY's ROE is +0.09%, compared to BCCOY's ROE of -0.50%. Regarding short-term risk, AMBBY is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check BCCOY's competition here
AMBBY vs CLLKF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CLLKF has a market cap of 159.9M. Regarding current trading prices, AMBBY is priced at $11.00, while CLLKF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CLLKF's P/E ratio is -0.96. In terms of profitability, AMBBY's ROE is +0.09%, compared to CLLKF's ROE of -0.50%. Regarding short-term risk, AMBBY and CLLKF have similar daily volatility (0.00).Check CLLKF's competition here
AMBBY vs PXMBF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, PXMBF has a market cap of 149.9M. Regarding current trading prices, AMBBY is priced at $11.00, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, AMBBY's ROE is +0.09%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, AMBBY and PXMBF have similar daily volatility (0.00).Check PXMBF's competition here
AMBBY vs EAPIF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, EAPIF has a market cap of 147.5M. Regarding current trading prices, AMBBY is priced at $11.00, while EAPIF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas EAPIF's P/E ratio is -0.59. In terms of profitability, AMBBY's ROE is +0.09%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, AMBBY is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check EAPIF's competition here
AMBBY vs EKDHF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, EKDHF has a market cap of 126.7M. Regarding current trading prices, AMBBY is priced at $11.00, while EKDHF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas EKDHF's P/E ratio is 29.39. In terms of profitability, AMBBY's ROE is +0.09%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, AMBBY is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check EKDHF's competition here
AMBBY vs AVHHL Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, AVHHL has a market cap of 123.2M. Regarding current trading prices, AMBBY is priced at $11.00, while AVHHL trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas AVHHL's P/E ratio is -2.76. In terms of profitability, AMBBY's ROE is +0.09%, compared to AVHHL's ROE of +4.77%. Regarding short-term risk, AMBBY and AVHHL have similar daily volatility (0.00).Check AVHHL's competition here
AMBBY vs AMEUF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, AMBBY is priced at $11.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, AMBBY's ROE is +0.09%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, AMBBY is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check AMEUF's competition here
AMBBY vs SOMNF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, SOMNF has a market cap of 111.7M. Regarding current trading prices, AMBBY is priced at $11.00, while SOMNF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas SOMNF's P/E ratio is -51.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, AMBBY and SOMNF have similar daily volatility (0.00).Check SOMNF's competition here
AMBBY vs JMDMF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, AMBBY is priced at $11.00, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, AMBBY's ROE is +0.09%, compared to JMDMF's ROE of N/A. Regarding short-term risk, AMBBY is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check JMDMF's competition here
AMBBY vs RSHUF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, AMBBY is priced at $11.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, AMBBY's ROE is +0.09%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, AMBBY is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RSHUF's competition here
AMBBY vs CKMTF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, AMBBY is priced at $11.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, AMBBY's ROE is +0.09%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, AMBBY and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here
AMBBY vs SNZZF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, SNZZF has a market cap of 75M. Regarding current trading prices, AMBBY is priced at $11.00, while SNZZF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas SNZZF's P/E ratio is -4.77. In terms of profitability, AMBBY's ROE is +0.09%, compared to SNZZF's ROE of -0.41%. Regarding short-term risk, AMBBY is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SNZZF's competition here
AMBBY vs BLOZF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, BLOZF has a market cap of 66.9M. Regarding current trading prices, AMBBY is priced at $11.00, while BLOZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas BLOZF's P/E ratio is -13.64. In terms of profitability, AMBBY's ROE is +0.09%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, AMBBY is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check BLOZF's competition here
AMBBY vs TLTFF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, TLTFF has a market cap of 60M. Regarding current trading prices, AMBBY is priced at $11.00, while TLTFF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas TLTFF's P/E ratio is -22.28. In terms of profitability, AMBBY's ROE is +0.09%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, AMBBY is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check TLTFF's competition here
AMBBY vs BRNHF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, AMBBY is priced at $11.00, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, AMBBY's ROE is +0.09%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, AMBBY and BRNHF have similar daily volatility (0.00).Check BRNHF's competition here
AMBBY vs NVYTF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, AMBBY is priced at $11.00, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, AMBBY's ROE is +0.09%, compared to NVYTF's ROE of -0.73%. Regarding short-term risk, AMBBY and NVYTF have similar daily volatility (0.00).Check NVYTF's competition here
AMBBY vs RDGL Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, RDGL has a market cap of 33.3M. Regarding current trading prices, AMBBY is priced at $11.00, while RDGL trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas RDGL's P/E ratio is -6.90. In terms of profitability, AMBBY's ROE is +0.09%, compared to RDGL's ROE of -1.26%. Regarding short-term risk, AMBBY is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RDGL's competition here
AMBBY vs PYNKF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, PYNKF has a market cap of 31.7M. Regarding current trading prices, AMBBY is priced at $11.00, while PYNKF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas PYNKF's P/E ratio is 5.04. In terms of profitability, AMBBY's ROE is +0.09%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, AMBBY is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check PYNKF's competition here
AMBBY vs POSC Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, POSC has a market cap of 27M. Regarding current trading prices, AMBBY is priced at $11.00, while POSC trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas POSC's P/E ratio is -5.56. In terms of profitability, AMBBY's ROE is +0.09%, compared to POSC's ROE of -4.69%. Regarding short-term risk, AMBBY is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check POSC's competition here
AMBBY vs MKEAF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, AMBBY is priced at $11.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, AMBBY's ROE is +0.09%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, AMBBY and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here
AMBBY vs TCLIF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, AMBBY is priced at $11.00, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas TCLIF's P/E ratio is -4.09. In terms of profitability, AMBBY's ROE is +0.09%, compared to TCLIF's ROE of +55995.52%. Regarding short-term risk, AMBBY is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check TCLIF's competition here
AMBBY vs KBBTF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, AMBBY is priced at $11.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, AMBBY's ROE is +0.09%, compared to KBBTF's ROE of N/A. Regarding short-term risk, AMBBY and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here
AMBBY vs DIZTF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, AMBBY is priced at $11.00, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, AMBBY's ROE is +0.09%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, AMBBY is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check DIZTF's competition here
AMBBY vs EMITF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, EMITF has a market cap of 17.8M. Regarding current trading prices, AMBBY is priced at $11.00, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas EMITF's P/E ratio is -7.62. In terms of profitability, AMBBY's ROE is +0.09%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, AMBBY and EMITF have similar daily volatility (0.00).Check EMITF's competition here
AMBBY vs IPDQF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, IPDQF has a market cap of 16.5M. Regarding current trading prices, AMBBY is priced at $11.00, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas IPDQF's P/E ratio is -0.81. In terms of profitability, AMBBY's ROE is +0.09%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, AMBBY and IPDQF have similar daily volatility (0.00).Check IPDQF's competition here
AMBBY vs GTHP Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, GTHP has a market cap of 15.3M. Regarding current trading prices, AMBBY is priced at $11.00, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas GTHP's P/E ratio is -5.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to GTHP's ROE of +0.82%. Regarding short-term risk, AMBBY is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check GTHP's competition here
AMBBY vs ASAPF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, ASAPF has a market cap of 14.4M. Regarding current trading prices, AMBBY is priced at $11.00, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas ASAPF's P/E ratio is -18.39. In terms of profitability, AMBBY's ROE is +0.09%, compared to ASAPF's ROE of -0.32%. Regarding short-term risk, AMBBY is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ASAPF's competition here
AMBBY vs MDXHF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, MDXHF has a market cap of 14.3M. Regarding current trading prices, AMBBY is priced at $11.00, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas MDXHF's P/E ratio is -4.37. In terms of profitability, AMBBY's ROE is +0.09%, compared to MDXHF's ROE of +0.58%. Regarding short-term risk, AMBBY is less volatile compared to MDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check MDXHF's competition here
AMBBY vs TMDIF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, AMBBY is priced at $11.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, AMBBY's ROE is +0.09%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, AMBBY is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check TMDIF's competition here
AMBBY vs VPTDF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, VPTDF has a market cap of 12.6M. Regarding current trading prices, AMBBY is priced at $11.00, while VPTDF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas VPTDF's P/E ratio is -3.66. In terms of profitability, AMBBY's ROE is +0.09%, compared to VPTDF's ROE of +1.07%. Regarding short-term risk, AMBBY is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check VPTDF's competition here
AMBBY vs ATBPF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, AMBBY is priced at $11.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, AMBBY's ROE is +0.09%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, AMBBY is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ATBPF's competition here
AMBBY vs LXXGF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, AMBBY is priced at $11.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, AMBBY's ROE is +0.09%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, AMBBY and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here
AMBBY vs ALRTF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, ALRTF has a market cap of 11.2M. Regarding current trading prices, AMBBY is priced at $11.00, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas ALRTF's P/E ratio is -0.44. In terms of profitability, AMBBY's ROE is +0.09%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, AMBBY is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ALRTF's competition here
AMBBY vs RMSL Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, RMSL has a market cap of 8.7M. Regarding current trading prices, AMBBY is priced at $11.00, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas RMSL's P/E ratio is 0.53. In terms of profitability, AMBBY's ROE is +0.09%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, AMBBY is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RMSL's competition here
AMBBY vs PLLWF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, AMBBY is priced at $11.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, AMBBY's ROE is +0.09%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, AMBBY is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check PLLWF's competition here
AMBBY vs PMEDF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, PMEDF has a market cap of 7.2M. Regarding current trading prices, AMBBY is priced at $11.00, while PMEDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas PMEDF's P/E ratio is -3.50. In terms of profitability, AMBBY's ROE is +0.09%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, AMBBY and PMEDF have similar daily volatility (0.00).Check PMEDF's competition here
AMBBY vs ODYY Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, ODYY has a market cap of 7M. Regarding current trading prices, AMBBY is priced at $11.00, while ODYY trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas ODYY's P/E ratio is -1.40. In terms of profitability, AMBBY's ROE is +0.09%, compared to ODYY's ROE of +0.58%. Regarding short-term risk, AMBBY is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ODYY's competition here
AMBBY vs USAQ Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, USAQ has a market cap of 6.8M. Regarding current trading prices, AMBBY is priced at $11.00, while USAQ trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas USAQ's P/E ratio is 30.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to USAQ's ROE of -8.25%. Regarding short-term risk, AMBBY and USAQ have similar daily volatility (0.00).Check USAQ's competition here
AMBBY vs BIEL Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, BIEL has a market cap of 6.3M. Regarding current trading prices, AMBBY is priced at $11.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas BIEL's P/E ratio is N/A. In terms of profitability, AMBBY's ROE is +0.09%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, AMBBY is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check BIEL's competition here
AMBBY vs QLIS Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, AMBBY is priced at $11.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas QLIS's P/E ratio is 2.22. In terms of profitability, AMBBY's ROE is +0.09%, compared to QLIS's ROE of -0.77%. Regarding short-term risk, AMBBY and QLIS have similar daily volatility (0.00).Check QLIS's competition here
AMBBY vs RHNMF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, AMBBY is priced at $11.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, AMBBY's ROE is +0.09%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, AMBBY is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RHNMF's competition here
AMBBY vs ADMT Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, ADMT has a market cap of 5M. Regarding current trading prices, AMBBY is priced at $11.00, while ADMT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas ADMT's P/E ratio is -7.47. In terms of profitability, AMBBY's ROE is +0.09%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, AMBBY is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ADMT's competition here
AMBBY vs ELXMF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, ELXMF has a market cap of 4.1M. Regarding current trading prices, AMBBY is priced at $11.00, while ELXMF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas ELXMF's P/E ratio is -0.72. In terms of profitability, AMBBY's ROE is +0.09%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, AMBBY is less volatile compared to ELXMF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ELXMF's competition here
AMBBY vs VANIW Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, AMBBY is priced at $11.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas VANIW's P/E ratio is N/A. In terms of profitability, AMBBY's ROE is +0.09%, compared to VANIW's ROE of -3.17%. Regarding short-term risk, AMBBY is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check VANIW's competition here
AMBBY vs CYDX Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, CYDX has a market cap of 3.2M. Regarding current trading prices, AMBBY is priced at $11.00, while CYDX trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas CYDX's P/E ratio is 0.79. In terms of profitability, AMBBY's ROE is +0.09%, compared to CYDX's ROE of +0.13%. Regarding short-term risk, AMBBY and CYDX have similar daily volatility (0.00).Check CYDX's competition here
AMBBY vs NGMDF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, NGMDF has a market cap of 2.9M. Regarding current trading prices, AMBBY is priced at $11.00, while NGMDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas NGMDF's P/E ratio is -1.27. In terms of profitability, AMBBY's ROE is +0.09%, compared to NGMDF's ROE of +0.34%. Regarding short-term risk, AMBBY is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check NGMDF's competition here
AMBBY vs TBRIF Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, TBRIF has a market cap of 2.8M. Regarding current trading prices, AMBBY is priced at $11.00, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas TBRIF's P/E ratio is -0.96. In terms of profitability, AMBBY's ROE is +0.09%, compared to TBRIF's ROE of +2.92%. Regarding short-term risk, AMBBY is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check TBRIF's competition here
AMBBY vs LLBO Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, LLBO has a market cap of 2.6M. Regarding current trading prices, AMBBY is priced at $11.00, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas LLBO's P/E ratio is N/A. In terms of profitability, AMBBY's ROE is +0.09%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, AMBBY is less volatile compared to LLBO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check LLBO's competition here
AMBBY vs VYCO Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, VYCO has a market cap of 2.3M. Regarding current trading prices, AMBBY is priced at $11.00, while VYCO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas VYCO's P/E ratio is -7.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to VYCO's ROE of +0.02%. Regarding short-term risk, AMBBY is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check VYCO's competition here
AMBBY vs KLYG Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, KLYG has a market cap of 1.5M. Regarding current trading prices, AMBBY is priced at $11.00, while KLYG trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas KLYG's P/E ratio is -12.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to KLYG's ROE of -0.19%. Regarding short-term risk, AMBBY and KLYG have similar daily volatility (0.00).Check KLYG's competition here
AMBBY vs FZMD Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, FZMD has a market cap of 1.5M. Regarding current trading prices, AMBBY is priced at $11.00, while FZMD trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas FZMD's P/E ratio is 2.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, AMBBY is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check FZMD's competition here
AMBBY vs ESMC Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, ESMC has a market cap of 1.3M. Regarding current trading prices, AMBBY is priced at $11.00, while ESMC trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas ESMC's P/E ratio is -5.67. In terms of profitability, AMBBY's ROE is +0.09%, compared to ESMC's ROE of -125.28%. Regarding short-term risk, AMBBY is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ESMC's competition here
AMBBY vs NUMD Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, NUMD has a market cap of 1.1M. Regarding current trading prices, AMBBY is priced at $11.00, while NUMD trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas NUMD's P/E ratio is 1.30. In terms of profitability, AMBBY's ROE is +0.09%, compared to NUMD's ROE of +0.22%. Regarding short-term risk, AMBBY is less volatile compared to NUMD. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check NUMD's competition here
AMBBY vs UAHC Comparison April 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.9B. In comparison, UAHC has a market cap of 896.6K. Regarding current trading prices, AMBBY is priced at $11.00, while UAHC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 34.38, whereas UAHC's P/E ratio is 0.43. In terms of profitability, AMBBY's ROE is +0.09%, compared to UAHC's ROE of +0.04%. Regarding short-term risk, AMBBY is less volatile compared to UAHC. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check UAHC's competition here